DK1429808T3 - Sammensætning på fast form, der indeholder ikke patogene bakteriesporer af Bacillus-typen - Google Patents

Sammensætning på fast form, der indeholder ikke patogene bakteriesporer af Bacillus-typen

Info

Publication number
DK1429808T3
DK1429808T3 DK02791476.1T DK02791476T DK1429808T3 DK 1429808 T3 DK1429808 T3 DK 1429808T3 DK 02791476 T DK02791476 T DK 02791476T DK 1429808 T3 DK1429808 T3 DK 1429808T3
Authority
DK
Denmark
Prior art keywords
solid form
bacterial spores
form composition
pathogenic bacterial
contain pathogenic
Prior art date
Application number
DK02791476.1T
Other languages
English (en)
Inventor
Tiziano Prato
Original Assignee
Sanofi Synthelabo Otc S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Otc S P A filed Critical Sanofi Synthelabo Otc S P A
Application granted granted Critical
Publication of DK1429808T3 publication Critical patent/DK1429808T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/742Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
DK02791476.1T 2001-07-27 2002-07-26 Sammensætning på fast form, der indeholder ikke patogene bakteriesporer af Bacillus-typen DK1429808T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001632A ITMI20011632A1 (it) 2001-07-27 2001-07-27 Composizione solida contenente spore di batteri non patogeni del genere bacillus
PCT/EP2002/008384 WO2003011341A1 (fr) 2001-07-27 2002-07-26 Composition solide contenant des spores de bacteries non pathogenes du genre bacillus

Publications (1)

Publication Number Publication Date
DK1429808T3 true DK1429808T3 (da) 2010-07-19

Family

ID=11448170

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02791476.1T DK1429808T3 (da) 2001-07-27 2002-07-26 Sammensætning på fast form, der indeholder ikke patogene bakteriesporer af Bacillus-typen

Country Status (32)

Country Link
US (2) US8039006B2 (da)
EP (1) EP1429808B1 (da)
JP (1) JP4913986B2 (da)
KR (2) KR100970787B1 (da)
CN (1) CN1323720C (da)
AT (1) ATE462448T1 (da)
AU (1) AU2002333278B2 (da)
BR (1) BRPI0211453B1 (da)
CA (1) CA2454389C (da)
CO (1) CO5560587A2 (da)
CY (1) CY1112608T1 (da)
DE (1) DE60235819D1 (da)
DK (1) DK1429808T3 (da)
EA (1) EA006847B1 (da)
ES (1) ES2356325T3 (da)
GE (2) GEP20063721B (da)
HK (1) HK1061644A1 (da)
HR (1) HRP20040066B1 (da)
HU (1) HU229652B1 (da)
IL (2) IL159807A0 (da)
IT (1) ITMI20011632A1 (da)
MA (1) MA27051A1 (da)
MX (1) MXPA04000835A (da)
NO (1) NO332656B1 (da)
NZ (1) NZ530743A (da)
PL (1) PL209647B1 (da)
PT (1) PT1429808E (da)
SI (1) SI1429808T1 (da)
TN (1) TNSN04018A1 (da)
UA (1) UA81225C2 (da)
WO (1) WO2003011341A1 (da)
ZA (1) ZA200400440B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599631B2 (en) 2001-01-26 2003-07-29 Nanogram Corporation Polymer-inorganic particle composites
KR100931948B1 (ko) * 2007-06-26 2009-12-15 영남대학교 산학협력단 제올라이트를 이용한 바실러스 포자의 열 안정성 향상 방법
BE1018018A6 (nl) 2008-02-28 2010-04-06 Gielen Cornelis Oplossing voor het biologisch reinigen van tandenborstels en bijhorende inrichting.
KR20110007168A (ko) * 2008-04-07 2011-01-21 바이엘 크롭사이언스 엘피 안정한 포자-함유 수성 제제
CA2720554C (en) 2008-04-07 2016-11-08 Bayer Cropscience Ag Combinations of biological control agents and insecticides or fungicides
IT1393931B1 (it) * 2009-02-25 2012-05-17 Neuroscienze Pharmaness S C A R L Composizione di spore di batteri non patogeni
WO2011120530A1 (en) * 2010-03-31 2011-10-06 Lifecycle Phama A/S Porous tablets as carriers for liquid formulations
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
CA3212215A1 (en) * 2012-11-23 2014-05-30 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3904502A3 (en) 2013-02-04 2022-02-23 Seres Therapeutics, Inc. Compositions and methods
AU2014212004B2 (en) 2013-02-04 2018-09-20 Seres Therapeutics, Inc. Compositions for treating or preventing or reducing the severity of clostridium difficile related diseases
CA2906921A1 (en) 2013-03-15 2014-09-18 Seres Therapeutics, Inc. Network-based microbial compositions and methods
CA3203756A1 (en) 2013-11-25 2015-05-28 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3082431A4 (en) 2013-12-16 2017-11-15 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
JP2020530840A (ja) 2017-08-14 2020-10-29 セレス セラピューティクス インコーポレイテッド 胆汁うっ滞性疾患を治療するための組成物及び方法
US11278578B2 (en) * 2018-09-02 2022-03-22 Sanzyme Biologics Private Limited Combination probiotic compositions and uses thereof
FR3125945A1 (fr) * 2021-08-03 2023-02-10 Setalg Composition pour protéger un microorganisme dans un environnement acide.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1061894A (en) * 1963-03-01 1967-03-15 Lucien Nouvel Therapeutically active bacterial preparations
GB8425487D0 (en) * 1984-10-09 1984-11-14 Agricultural Genetics Co Strain of bacillus thuringiensis
DE3707160A1 (de) 1987-03-06 1988-09-15 Hoechst Ag Bacillus polymyxa enthaltende mittel zur verabreichung an tiere
JPH0761255B2 (ja) * 1990-10-31 1995-07-05 旭化成工業株式会社 安定化芽胞形成生菌製剤の製造法
DE4404702A1 (de) 1994-02-15 1995-08-31 Hoechst Schering Agrevo Gmbh Wasserdispergierbare Granulate auf der Basis lebender Organismen
WO1995022962A1 (en) * 1994-02-23 1995-08-31 Bm Research A/S Controlled release composition
WO1995034291A1 (en) * 1994-06-15 1995-12-21 Dumex-Alpharma A/S Pellets
DE4442255A1 (de) 1994-11-28 1996-05-30 Bayer Ag Schädlingsbekämpfungsmittel
JP3180886B2 (ja) * 1995-06-07 2001-06-25 旭化成株式会社 動物成長促進剤
CA2326874C (en) * 1998-04-01 2010-05-25 Ganeden Biotech, Inc. Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
US6924133B1 (en) * 1999-10-01 2005-08-02 Novozymes A/S Spray dried enzyme product
US6387874B1 (en) * 2001-06-27 2002-05-14 Spartan Chemical Company, Inc. Cleaning composition containing an organic acid and a spore forming microbial composition

Also Published As

Publication number Publication date
BRPI0211453B1 (pt) 2018-04-03
CN1323720C (zh) 2007-07-04
GEP20063721B (en) 2006-01-10
CA2454389A1 (fr) 2003-02-13
TNSN04018A1 (fr) 2006-06-01
US20040241772A1 (en) 2004-12-02
SI1429808T1 (sl) 2010-11-30
EP1429808B1 (fr) 2010-03-31
NO332656B1 (no) 2012-11-26
EP1429808A1 (fr) 2004-06-23
HRP20040066B1 (en) 2012-02-29
IL159807A0 (en) 2004-06-20
WO2003011341A1 (fr) 2003-02-13
KR20090099022A (ko) 2009-09-18
ATE462448T1 (de) 2010-04-15
HRP20040066A2 (en) 2004-06-30
US8551498B2 (en) 2013-10-08
GEP20053721B (en) 2006-01-10
DE60235819D1 (de) 2010-05-12
IL159807A (en) 2010-05-31
CA2454389C (fr) 2011-07-12
MXPA04000835A (es) 2004-05-14
MA27051A1 (fr) 2004-12-20
UA81225C2 (en) 2007-12-25
HUP0402024A3 (en) 2005-06-28
ITMI20011632A0 (it) 2001-07-27
NO20040347L (no) 2004-03-26
ES2356325T3 (es) 2011-04-07
US20120009167A1 (en) 2012-01-12
EA200400072A1 (ru) 2004-08-26
CO5560587A2 (es) 2005-09-30
BR0211453A (pt) 2004-08-17
PL209647B1 (pl) 2011-09-30
KR100970787B1 (ko) 2010-07-16
PL366984A1 (en) 2005-02-07
JP2004538311A (ja) 2004-12-24
JP4913986B2 (ja) 2012-04-11
US8039006B2 (en) 2011-10-18
CN1558776A (zh) 2004-12-29
ZA200400440B (en) 2005-03-30
HU229652B1 (en) 2014-03-28
ITMI20011632A1 (it) 2003-01-27
EA006847B1 (ru) 2006-04-28
HK1061644A1 (en) 2004-09-30
HUP0402024A2 (hu) 2005-01-28
NZ530743A (en) 2005-08-26
AU2002333278B2 (en) 2007-05-31
KR20040032868A (ko) 2004-04-17
PT1429808E (pt) 2010-06-23
CY1112608T1 (el) 2016-02-10

Similar Documents

Publication Publication Date Title
DK1429808T3 (da) Sammensætning på fast form, der indeholder ikke patogene bakteriesporer af Bacillus-typen
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
CY1110230T1 (el) Αναστολεις γυρασης και χρησεις αυτων
EP2949644A3 (en) Substituted tetracycline compounds
SE0102327D0 (sv) A novel engineered superantigen for human therapy
MY125941A (en) New lactobacillus strains preventing diarrhoea caused by pathogenic bacteria
ATE386534T1 (de) Orale darreichungsform enthaltend probiotische bakterien
NZ597046A (en) Use of alpha-toxin for treating and preventing staphylococcus infections
BR0012992A (pt) Bifidobactérias que previnem a diarréia causada por bactérias patogênicas
ECSP055725A (es) Formulaciones nutricionales que contienen sustancias simbióticas
FI963232A (fi) Antimikrobisena aineena käytettävä hapotettu nitriitti
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
WO2006021001A3 (en) Amphiphilic polynorbornene derivatives and methods of using the same
BR0112463A (pt) Composições biocidas e métodos e sistemas que empregam as mesmas
TR200200300T2 (tr) İshali önlemeye elverişli bifidobakteriler.
ATE474582T1 (de) Pharmazeutische zusammensetzung enthaltend glucan aus mikroalgen
WO2005086669A3 (en) Hydrogenase deficient bacterial strains
ATE369145T1 (de) Aus einer bifidobakterien-kultur gewonnener immunomodulator und diesen enthaltende zusammensetzungen
TW200724152A (en) Oligopeptide, derivative thereof, and pharmaceutical composition comprising the same
WO2005034971A3 (en) Antiviral agent
WO2006066224A3 (en) Virulence targeted antibiotics
RU2004108554A (ru) Пробиотическая композиция для животных и птицы
UA56313U (ru) Вакцина «эквисан» ассоциируемая инактивированная против клостридиозов, эшерихиозов и кокковых инфекций коней
UA2492U (uk) Штам бактерій escherichia coli hm-2 для виготовлення бактерійних препаратів
RU2006124901A (ru) Косметическое средство